Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.
Standardized microfluidic assessment of red blood cell-mediated microcapillary occlusion: Association with clinical phenotype and hydroxyurea responsiveness in sickle cell disease.
复制标题
红细胞介导的微毛细血管阻塞的标准化微流控评估:镰状细胞病的临床表型和羟基脲反应性
DOI:
10.1111/micc.12662
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Gurkan UA
中科院分区:
文献类型:
--
作者:
Man Y;Kucukal E;An R;Bode A;Little JA;Gurkan UA
We present a standardized in vitro microfluidic assay and Occlusion Index (OI) for the assessment of red blood cell (RBC)-mediated microcapillary occlusion and its clinical associations in sickle cell disease (SCD). RBC-mediated microcapillary occlusion represented by OI and its clinical associations were assessed for 7 subjects with hemoglobin-SC disease (HbSC), 18 subjects with homozygous SCD (HbSS), and 5 control individuals (HbAA). We identified two sub-populations with HbSS based on the OI distribution. HbSS subjects with relatively higher OIs had significantly lower hemoglobin levels, lower fetal hemoglobin (HbF) levels, and lower mean corpuscular volume (MCV), but significantly higher serum lactate dehydrogenase levels and absolute reticulocyte counts, compared to subjects with HbSS and lower OIs. HbSS subjects who had relatively higher OIs were more likely to have had a concomitant diagnosis of intrapulmonary shunting (IPS). Further, lower OI associated with hydroxyurea (HU) responsiveness in subjects with HbSS, as evidenced by significantly elevated HbF levels and MCV. We demonstrated that RBC mediated microcapillary occlusion and OI associated with subject clinical phenotype and HU responsiveness in SCD. The presented standardized microfluidic assay may be useful for evaluating clinical phenotype and assessing therapeutic outcomes in SCD, including emerging targeted and curative treatments that aim to improve RBC deformability and microcirculatory health.
登录
查看更多内容
DOI:
10.4084/mjhid.2017.063
发表时间:
2017-11-01
影响因子:
3.2
作者:
Adeodu, Oluwagbemiga O.;Akinlosotu, Morenike A.;Oseni, Saheed B. A.
通讯作者:
Oseni, Saheed B. A.
影响因子:
20.3
作者:
Kato, GJ;McGcwan, V;Gladwin, MT
通讯作者:
Gladwin, MT
DOI:
10.1016/j.trsl.2016.03.008
发表时间:
2016-07
期刊:
Translational research : the journal of laboratory and clinical medicine
影响因子:
--
作者:
Alapan Y;Kim C;Adhikari A;Gray KE;Gurkan-Cavusoglu E;Little JA;Gurkan UA
通讯作者:
Gurkan UA
影响因子:
7.5
作者:
Desai, Payal C.;Brittain, Julia E.;Ataga, Kenneth I.
通讯作者:
Ataga, Kenneth I.
影响因子:
5
作者:
Diez-Silva M;Dao M;Han J;Lim CT;Suresh S
通讯作者:
Suresh S